New Drug May Treat Brain Injuries, MS, Parkinson's and Alzheimer's

Studies indicate that a new drug recently tested may reduce or prevent neurological damage. It is expected that it will protect users against cognitive impairments.

The new drug, MW151 and MW189, is expected to reduce inflammation in the brain. Neuroinflammation is increasingly believed to play a major role in the diseases of Multiple Sclerosis, Parkinson's, Alzheimer's and dementia as well as brain injuries and strokes. Besides preventing the development of these neurological diseases, it is believed it will reduce the neurological damage caused by closed head traumatic injuries and strokes especially if introduced within a certain time period.

These two drugs are believed to prevent the damaging overproduction of brain proteins which contribute to the development of degenerative neurological diseases as well as the neurological damage caused by brain injuries and strokes. It is believed that it will protect against the damage associated with learning and memory deficiencies as well as other cognitive impairments.

The therapy time window, however, is considered critical. A study indicated the best time for the drug to be given someone with a brain injury or stroke is three to six hours following the injury. By doing so, it could possibly prevent future problems such as cognitive impairments or the risk of epileptic seizures.

Studies indicate that by giving the drug, a pill taken orally, before symptoms become readily apparent, in the case of Alzheimer's Parkinson's or Multiple Sclerosis, may be a promising therapeutic strategy for these neurodegenerative diseases. It is considered to be a preventative drug when given during the early stages of a neurological disease before the disease progresses. If taken in the early to middle stages, it will help to reduce inflammation.

The first human Phase I climical trial has been done on the drug and it has been found to be safe in humans. Researchers are now waiting for funding in order to begin further clinical trials. Those working with the drug feel that it will best be used in combination with current therapies targeting neurodegenerative disorders, brain injuries and strokes.

The body has proven itself to have great repair mechanisms if given a chance. If a pill can control, prevent or reduce cognitive impairments, then the body has a chance to rebuild itself. This healing process can be done when obstacles have been removed from the body and mind. But it can also heal with determination and sometimes just because that's what the body does. But with neurodegenerative diseases, etc. extra help with this drug will go a long way in warding off these debilitating diseases and eliminating the devastating results of head injuries.

It is believed that this drug will help many people in their fight against these neurodegenerative diseases, brain injury and strokes saving many sufferers and families from hopelessness and despair.